(Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -25.29%46.26B | -19.12%21.35B | 17.62%129.71B | 22.11%97.66B | 27.16%61.91B | 14.03%26.39B | 45.72%110.27B | 45.10%79.98B | 40.83%48.69B | 45.67%23.15B |
Special items of operating revenue | ---- | 34.27%219.99M | ---- | 34.31%525.76M | ---- | 33.97%163.84M | ---- | -1.05%391.45M | ---- | -8.84%122.3M |
Operating income | -25.29%46.26B | -18.79%21.57B | 17.62%129.71B | 22.17%98.18B | 27.16%61.91B | 14.14%26.56B | 45.72%110.27B | 44.77%80.37B | 40.83%48.69B | 45.21%23.27B |
Cost of sales | 26.42%-44.1B | ---- | -16.59%-124.18B | ---- | -28.75%-59.94B | ---- | -48.39%-106.51B | ---- | -41.25%-46.55B | ---- |
Operating expenses | 26.42%-44.1B | 21.76%-19.82B | -16.59%-124.18B | -21.04%-90.88B | -28.75%-59.94B | -16.59%-25.34B | -48.39%-106.51B | -46.57%-75.08B | -41.25%-46.55B | -44.79%-21.73B |
Gross profit | 9.00%2.15B | 42.83%1.74B | 46.83%5.53B | 38.10%7.3B | -7.53%1.97B | -20.60%1.22B | -3.45%3.76B | 23.26%5.29B | 32.26%2.14B | 51.47%1.54B |
Selling expenses | -10.15%-2.83B | -19.96%-1.28B | -57.94%-6.2B | -16.16%-4.26B | -8.36%-2.57B | 7.69%-1.06B | 9.61%-3.92B | -15.62%-3.66B | -22.05%-2.37B | -38.34%-1.15B |
Administrative expenses | -0.51%-2.53B | -25.15%-1.02B | -10.60%-5.66B | 3.01%-2.96B | -5.99%-2.51B | 14.49%-817.97M | -12.26%-5.11B | -13.70%-3.06B | -16.75%-2.37B | -39.88%-956.55M |
Research and development expenses | ---- | 5.50%-375.36M | ---- | -38.43%-1.31B | ---- | -65.00%-397.19M | ---- | -24.51%-947.2M | ---- | 7.52%-240.72M |
Profit from asset sales | ---- | 718.65%36.53M | ---- | 164.43%29.37M | ---- | 45.96%4.46M | ---- | -48.73%11.11M | ---- | 36.84%3.06M |
Revaluation surplus | ---- | -115.70%-8.3M | ---- | 101.94%5.27M | ---- | 147.78%52.88M | ---- | -1,264.42%-271.11M | ---- | -58.84%-110.67M |
-Changes in the fair value of other assets | ---- | -115.70%-8.3M | ---- | 101.94%5.27M | ---- | 147.78%52.88M | ---- | -1,264.42%-271.11M | ---- | -58.84%-110.67M |
Impairment and provision | 5.43%-210.01M | 73.60%-91.27M | 27.37%-455.9M | 8.10%-719.4M | -181.91%-222.06M | -472.98%-345.74M | -337.54%-627.72M | -1,377.50%-782.85M | -14,650.94%-78.77M | -223.85%-60.34M |
-Other impairment is provision | 5.43%-210.01M | 73.60%-91.27M | 27.37%-455.9M | 8.10%-719.4M | -181.91%-222.06M | -472.98%-345.74M | -337.54%-627.72M | -1,377.50%-782.85M | -14,650.94%-78.77M | -223.85%-60.34M |
Operating interest expense | ---- | -10.71%-34.39M | ---- | -94.34%-94.7M | ---- | -24.09%-31.07M | ---- | 35.14%-48.73M | ---- | 13.06%-25.04M |
Special items of operating profit | 799.39%2.66B | -17.85%2.52B | 350.25%1.94B | -39.36%7.77B | -18.07%295.34M | -29.55%3.06B | -151.15%-774.77M | 42.86%12.82B | -2.52%360.49M | 20.95%4.35B |
Operating profit | 75.00%-758.97M | -17.81%909.51M | 27.47%-4.84B | -53.78%3.59B | -30.50%-3.04B | -61.27%1.11B | -84.12%-6.68B | 46.37%7.76B | -16.85%-2.33B | 22.44%2.86B |
Financing income | -20.73%242.27M | ---- | 46.74%484.99M | ---- | 125.74%305.63M | ---- | 464.43%330.52M | ---- | 74.78%135.39M | ---- |
Financing cost | -61.47%-323.81M | 33.94%51.15M | -32.84%-467.32M | 272.95%276.86M | -26.42%-200.54M | 1,289.01%38.19M | 17.29%-351.78M | 167.43%74.24M | 16.11%-158.62M | 94.12%-3.21M |
Share of profits of associates | -62.06%2.01B | ---- | -40.64%8.35B | ---- | -37.03%5.3B | ---- | 23.34%14.07B | ---- | 33.09%8.42B | ---- |
Special items of earning before tax | ---- | 12.57%9.03M | ---- | -527.92%-18.72M | ---- | 173.54%8.02M | ---- | -44.17%4.37M | ---- | -36.24%2.93M |
Earning before tax | -50.61%1.17B | -15.88%969.69M | -52.16%3.52B | -50.95%3.85B | -60.95%2.37B | -59.65%1.15B | -0.58%7.37B | 50.76%7.84B | 43.72%6.07B | 25.11%2.86B |
Tax | -82.23%45.44M | -20.18%122.48M | -59.77%215.46M | 57.77%320.34M | 263.71%255.75M | 11.23%153.45M | 247.49%535.54M | 134.19%203.04M | -46.24%70.32M | 109.14%137.95M |
After-tax profit from continuing operations | -53.69%1.22B | -16.39%1.09B | -52.68%3.74B | -48.21%4.17B | -57.23%2.63B | -56.38%1.31B | 4.47%7.9B | 52.13%8.05B | 41.02%6.14B | 27.47%2.99B |
After-tax profit from non-continuing business | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 |
Earning after tax | -53.69%1.22B | -16.39%1.09B | -52.68%3.74B | -48.21%4.17B | -57.23%2.63B | -56.38%1.31B | 4.47%7.9B | 52.13%8.05B | 41.02%6.14B | 27.47%2.99B |
Minority profit | 11.84%-300.49M | 44.66%-128.19M | -824.37%-688.68M | -1,993.02%-343.79M | -629.04%-340.85M | -1,553.93%-231.65M | -236.29%-74.5M | -415.78%-16.43M | 295.49%64.43M | 15.60%-14.01M |
Profit attributable to shareholders | -48.88%1.52B | -20.65%1.22B | -44.49%4.43B | -44.05%4.51B | -51.16%2.97B | -48.89%1.54B | 6.22%7.98B | 52.59%8.06B | 40.06%6.07B | 27.17%3.01B |
Basic earnings per share | -50.00%0.14 | -20.00%0.12 | -45.45%0.42 | -44.87%0.43 | -52.54%0.28 | -48.28%0.15 | 5.48%0.77 | 52.94%0.78 | 40.48%0.59 | 26.09%0.29 |
Diluted earnings per share | -50.00%0.14 | -20.00%0.12 | -45.45%0.42 | -44.87%0.43 | -51.72%0.28 | -48.28%0.15 | 5.48%0.77 | 50.00%0.78 | 38.10%0.58 | 26.09%0.29 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Auditor | -- | -- | Shinnaganaka & Chung Certified Public Accountants (Special General Partnership) | -- | -- | -- | Shinnaganaka & Chung Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data